Company: NIVFW
Filing Date: 2025-10-31
Form Type: 424B3
Source: 0001213900-25-104469
Chunk: 159

Company: NewGenIvf Group Ltd
Filing Date: 2025-10-31
Form: 424B3
Chunk 159
---
 the sperm. The stained sperm cells are analyzed
one by one by a flow cytometer, in which cells pass through a laser to make the stain attach to the DNA fluoresce. The sperm containing
the X chromosome (which have more DNA and therefore more stain) will shine brighter than the sperm containing the Y chromosome.
The flow cytometer uses a special software to identify X and Y chromosome sperm based on their fluorescence signature. The
sperm carrying the chromosome that will produce the desired gender are separated from the rest of the sample -resulting in an enriched
sperm sample ready for use.

NewGenIvf held an exclusive
license granted by a division of GIVF, MicroSort International, to use the MicroSort technology in Thailand and Cambodia. MicroSort’s
licenses for NewGenIvf’s operation in Thailand and Cambodia were each provided under a lease and service agreement. In April 2019,
First Fertility PGS entered into a Lease and Services Agreement with MicroSort International to use MicroSort equipment in Thailand and
in March 2019, Phnom Penh Center entered into a Lease and Services Agreement with MicroSort International to use MicroSort equipment
in Cambodia (together, the “Lease and Services Agreements”). Pursuant to the Lease and Services Agreements, First Fertility
PGS and Phnom Penh Center each had the exclusive right to utilize the MicroSort equipment and to market and sell MicroSort sperm sorting
services in Thailand and Cambodia, respectively. MicroSort International was responsible for the maintenance of MicroSort equipment and
technical and engineering support. The term of each Lease and Service Agreements was initially from 2019 to 2024, which shall be automatically
renewed for one year unless a written notice of at least 180 days prior to the intended termination date is provided. The consideration
under each of the Lease and Services Agreements was US$9,000 per month after six months.

<div align='center'>88</div>

On February 28, 2025, NewGenIvf
completed its acquisition of the MicroSort technology from Genetics & IVF Institute, Inc. (“GIVF”). Pursuant to a Purchase
Agreement dated January 21, 2025 between NewGenIvf and GIVF (“Purchase Agreement”), NewGenIvf purchased all of the Assets
(as defined in the Purchase Agreement) and IP Licenses (as defined in the Purchase Agreement) relating to the MicroSort technology from
GIVF